Authors: Hermien H. Dijk; Lisa M. Wessels; Margaret Constanti; Barbara J. van den Hoofdakker; Pieter J. Hoekstra; Annabeth P. Groenman · Research

Which ADHD Treatments Provide the Best Value for Money?

A comprehensive review of research examining the cost-effectiveness of different ADHD treatments across age groups.

Source: Dijk, H. H., Wessels, L. M., Constanti, M., van den Hoofdakker, B. J., Hoekstra, P. J., & Groenman, A. P. (2021). Cost-Effectiveness and Cost Utility of Treatment of Attention-Deficit/Hyperactivity Disorder: A Systematic Review. Journal of Child and Adolescent Psychopharmacology, 31(9), 578-596. https://doi.org/10.1089/cap.2021.0068

What you need to know

  • Most ADHD treatments are cost-effective compared to no treatment
  • Stimulant medications appear particularly cost-effective for children and adolescents
  • More research is needed on cost-effectiveness of treatments for adults and behavioral interventions

The Value of Understanding Treatment Costs

Imagine having to choose between two equally effective treatments for ADHD, but one costs significantly more than the other. Which would you choose? This is the kind of decision that healthcare systems face regularly. With limited healthcare budgets and rising costs, understanding which treatments provide the best value for money is crucial - not just for systems and insurers, but for families affected by ADHD who often face significant out-of-pocket expenses.

The Current Treatment Landscape

ADHD treatments generally fall into two main categories: medication (like stimulants and non-stimulants) and behavioral interventions (such as parent training and cognitive behavioral therapy). While medication is most commonly prescribed, many guidelines recommend starting with behavioral interventions, especially for younger children. But which approaches give us the most bang for our buck?

Key Findings About Medication

The research shows that stimulant medications are generally cost-effective for treating ADHD in children and adolescents compared to no treatment. Extended-release formulations, though often more expensive upfront, may provide better value than immediate-release versions because they last longer and may improve treatment adherence.

For non-stimulant medications like atomoxetine, the picture is more mixed. These medications appear cost-effective for people who can’t take stimulants (due to side effects or other issues), but may not be the most economical first choice for others.

Behavioral Treatment Value

While we have less cost-effectiveness data on behavioral treatments compared to medications, the available research suggests parent training programs can be cost-effective, especially for younger children. Group-based behavioral interventions tend to provide better value than individual therapy due to lower per-person costs.

What This Means for You

When discussing treatment options with healthcare providers, consider asking about:

  • Both the effectiveness and costs of different treatment options
  • Whether less expensive alternatives might work equally well
  • If combination treatments might provide better value
  • What your insurance covers and potential out-of-pocket costs
  • Whether group-based behavioral programs are available in your area

Conclusions

  • Most ADHD treatments provide good value compared to no treatment at all
  • Stimulant medications are generally cost-effective, particularly for children and teens
  • Behavioral treatments can be cost-effective, especially in group formats
Back to Blog

Related Articles

View All Articles »